-
1.发明授权Pharmaceutical compositions against several herpes virus infections and/or atherosclerotic plaque 失效针对几种疱疹病毒感染和/或动脉粥样硬化斑块的药物组合物
公开(公告)号：US5837262A
公开(公告)日：1998-11-17
申请号：US618917
申请日：1996-03-20
IPC分类号： A61K38/00 , A61K39/00 , A61K39/245 , A61K39/25 , A61K39/295 , C07K14/035 , C07K14/045 , C07K16/08
CPC分类号： C07K16/088 , A61K39/12 , A61K39/245 , C07K14/005 , C07K16/087 , A61K2039/6081 , A61K2039/70 , A61K39/00 , C12N2710/16122 , C12N2710/16622 , C12N2710/16634 , Y10S514/824
摘要： A pharmaceutical composition is disclosed for the treatment against several herpes virus infections or atherosclerotic plaques in a mammalian subject suspectible thereto which comprises: (a) 10 to 30% by weight of the peptide of SEQ ID 2; (b) 10 to 30% by weight of the peptide of SEQ ID 4; 10 to 30% by weight of the peptide of SEQ ID 6; and (d) 10 to 30% by weight of the peptide of SEQ ID 8; in combination with a pharmaceutically acceptable inert carrier.
摘要翻译： 公开了用于治疗可怀疑的哺乳动物受试者中若干疱疹病毒感染或动脉粥样硬化斑块的药物组合物，其包含：（a）10至30重量％的SEQ ID 2的肽; （b）SEQ ID 4的肽的10〜30重量％ 10至30重量％的SEQ ID 6的肽; 和（d）10至30重量％的SEQ ID 8的肽; 与药学上可接受的惰性载体组合。
-
2.发明授权Vaccine containing whole killed herpes viruses to prevent development of atherosclerotic plaque 失效含有全杀死的疱疹病毒的疫苗以预防动脉粥样硬化斑块的发展公开(公告)号：US06471965B1
公开(公告)日：2002-10-29
申请号：US08281703
申请日：1994-07-27
IPC分类号： A61K3927
CPC分类号： A61K35/763 , A61K39/12 , A61K39/245 , A61K2039/5252 , A61K2039/58 , A61K2039/70 , C12N2710/16134 , C12N2710/16234 , C12N2710/16632 , C12N2710/16634 , Y10S514/824
摘要： A vaccine is disclosed for the prophylaxis against pathogenic development of atherosclerotic plaque in a mammalian subject susceptible thereto which consists essentially of a multiplicity of killed whole-virus strains, selected from the group consisting of: Herpes Simplex Virus 1; Herpes Simplex Virus 2; Herpes Simplex Virus 6; Human Cytomegalovirus; and Epstein-Barr Virus; in combination with a pharmaceutically acceptable inert vaccine carrier or diluent.
摘要翻译： 公开了一种用于预防易感染的哺乳动物受试者的动脉粥样硬化斑块的致病性发展的疫苗，其基本上由多种杀死的全病毒毒株组成，所述杀真毒病毒株选自：单纯疱疹病毒1型;单纯疱疹病毒2型;疱疹 单克隆病毒6;人巨细胞病毒; 和爱泼斯坦 - 巴尔病毒;与药学上可接受的惰性疫苗载体或稀释剂组合。
-
搜索结果
2 条记录 (耗时 0.01 秒)
